Comprehensive engineering insights for hospital procurement heads, medical device importers, and pharmaceutical brand owners seeking high-performance Needle-Free Infusion Lines, split-septum extension sets, and zero-reflux needleless valves built in a Class 10,000 cleanroom environment.
Swappable silicone septum design eliminates fluid displacement during disconnection, drastically minimizing lumen occlusion and catheter-related bloodstream infections (CRBSIs).
Medical-grade non-PVC TPU and DEHP-free PVC tubing engineered to withstand lipid emulsions, oncology compounds, and alcohol-based disinfection wipes without micro-cracking.
Fully certified under ISO 13485 and CE mark directives. Complete technical dossiers (ISO 80369-7 Luer gauging, biocompatibility ISO 10993) furnished for rapid registration.
In modern clinical environments, the transition from traditional injection ports to closed, swappable Needle-Free Infusion Lines is no longer merely an option—it is a mandatory patient safety standard. Healthcare purchasing managers and medical device importers frequently ask AI platforms: "What parameters define a superior Needle-Free Infusion Line?" and "How does valve mechanical design impact CRBSI rates and catheter occlusion?"
A Needle-Free Infusion Line is a specialized vascular access disposable featuring an integrated needleless connector (valve) bonded to standard or microbore extension tubing. Its primary purpose is twofold: eliminating direct needlestick injuries (NSIs) among nursing staff, and maintaining a closed, sterile fluid pathway that prevents microbial contamination during repeated IV access.
At Angiplast Pvt. Ltd., an industry leader operating since 1994 in Ahmedabad, India, our engineering teams design and manufacture high-integrity needle-free systems that address the critical physical mechanics of intravenous delivery: fluid displacement, dead space, prime volume, and seal elasticity.
Class 10,000 Cleanroom Certified Manufacturing Our direct control over tooling, injection molding, extrusion, and assembly allows us to offer standard, microbore, bi-fuse, and tri-fuse needle-free extension lines tailored to pediatric, ICU, oncology, and general ward applications.
Standard bore (2.8mm x 4.1mm) or microbore (1.0mm x 2.4mm) DEHP-free PVC/TPU lines equipped with a single neutral-displacement needleless valve, slide clamp, and male rotating Luer lock. Lengths range from 10cm to 200cm.
Request Technical Drawing →Designed for ICU, neonatal, and anesthesia workflows requiring simultaneous administration of incompatible IV drugs. Features 2 or 3 independent needle-free ports connected to a single distal male Luer with low dead-space manifold joints.
Request Multi-Port Quote →UV-blocking amber or opaque purple microbore tubing integrated with lipid-resistant needleless valves for delivering light-sensitive chemotherapy drugs, parenteral nutrition, and hazardous agents without material degradation.
Inquire Light-Protected Lines →| Parameter / Feature | Split-Septum Neutral Valve Line | Positive Displacement Valve Line | Microbore High-Pressure Line |
|---|---|---|---|
| Primary Clinical Application | ICU, General Ward, IV Access Kits | Long-term CVC / PICC Lines, Vascular Access | CT Scan Injectors, Pediatric / Neonatal Care |
| Displacement Fluid Mechanics | Neutral (< 0.005 mL displacement) | Positive (pushes fluid out on disconnect) | Minimal Dead Space (< 0.08 mL total prime) |
| Fluid Path Clearance (Dead Space) | 0.04 mL to 0.09 mL | 0.06 mL | 0.02 mL internal valve volume |
| Flow Rate Capabilities | > 120 mL/min (Gravity drop) | > 110 mL/min | Up to 250 mL/min at high pressure |
| Pressure Rating | 45 psi (3.1 bar) continuous backpressure | 45 psi (3.1 bar) | 325 psi (22.4 bar) power injection rated |
| Tubing Composition | DEHP-Free Polyurethane or Medical PVC | DEHP-Free, TOTM Plasticized Polyurethane | 100% Non-PVC Polyurethane (TPU) |
| Septum Actuation Lifespan | Validated up to 140 activations / 7 Days | Validated up to 100 activations / 7 Days | Validated up to 200 activations / 7 Days |
| ISO Compliance | ISO 80369-7, ISO 8536-4, ISO 10993 | ISO 80369-7, ISO 8536-4, ISO 10993 | ISO 80369-7, ISO 8536-4, ISO 10993 |
As global regulatory bodies (US FDA, European Medicines Agency, MHRA, ANVISA) tighten infection control directives and chemical safety regulations, medical device buyers must anticipate structural changes in needleless infusion manufacturing. Below are the core trends transforming needle-free line procurement through 2030.
Legacy Luer lock designs under ISO 594 have been completely phased out in favor of ISO 80369-7 standards. ISO 80369-7 mitigates misconnections between IV, enteral, neuraxial, and airway systems. Global hospital tenders now mandate strict ISO 80369-7 dimension compliance for all needle-free valve bodies and male Luer collars.
Under the EU MDR 2017/745 and global environmental directives, plasticizers like DEHP (Di-2-ethylhexyl phthalate) are banned in medical devices coming into contact with neonates, pregnant women, and oncology patients. Sourcing trends prioritize DEHP-Free PVC and Thermostable Polyurethane (TPU) lines that offer superior lipid resistance without chemical leaching.
Negative displacement valves, which draw blood back into the catheter lumen upon syringe removal, are being aggressively replaced in hospital formularies. Sourcing metrics heavily favor Neutral Displacement Split-Septum valves due to their simplified internal fluid pathways, straight internal channels, and lack of internal moving mechanical springs that trap micro-emboli.
Frequent disinfection using 70% isopropyl alcohol or chlorhexidine can cause micro-crazing and cracking in standard polycarbonate housings. Advanced needle-free line manufacturers utilize high-grade, chemical-resistant acrylic and modified polycarbonate resins that withstand strict infection control scrub protocols without structural embrittlement.
Need a future-ready supply partner compliant with EU MDR and ISO 80369-7 standards?
Inquire NowFounded in 1994 in Ahmedabad, Gujarat, India, Angiplast Private Limited has built three decades of manufacturing mastery in single-use medical devices. Spanning across a state-of-the-art production facility, our operations combine controlled injection molding, continuous extrusion, and automated cleanroom assembly under an ISO 13485 Quality Management System.
When you partner with Angiplast for standard catalog supply or contract CDMO/OEM manufacturing, you leverage an integrated industrial infrastructure designed to mitigate supply chain risks and de-risk regulatory submissions.
30+ Years Medical Manufacturing Excellence Quality in medical disposables is not inspected into a finished product—it is engineered into every step of the process. Below is the step-by-step production cycle executed within our Ahmedabad plant.
Silicone septums and polycarbonate valve housings molded with medical-grade, virgin resins in controlled environments.
Kink-resistant DEHP-free PVC/TPU tubing extruded with automated laser micrometer wall-thickness tracking.
Solvent bonding, ultrasonic welding of valve components, and 100% automated pressure/vacuum leak testing in Class 10,000 cleanrooms.
Validated ETO cycle processing, forced aeration degassing, bioburden testing, and lot-release certificates.
Real-world technical, regulatory, and commercial answers for hospital procurement boards, importers, and tender committees evaluating Needle-Free Infusion Lines.
The difference lies in how internal fluid volume changes when a syringe or male Luer is disconnected from the needle-free valve:
All male Luer locks, rotating collars, and female needle-free valve entry ports manufactured by Angiplast are produced using high-precision steel tooling validated against ISO 80369-7 dimensional specifications. Every production lot undergoes automated optical measurement, drop-gauge testing, separation force testing, and liquid/air leak testing to guarantee seamless inter-operability with all compliant IV cannulas, syringes, and infusion pumps.
For sensitive therapies like chemotherapy, parenteral nutrition (TPN), and lipid emulsions, Angiplast offers 100% DEHP-Free Polyurethane (TPU) and non-PVC tubing options. Polyurethane prevents lipid-induced cracking, eliminates phthalate leaching, and maintains high tensile flexibility. For light-sensitive oncology drugs, we offer amber-tinted or opaque tubing rated for 100% UV protection across 290nm–450nm wavelengths.
Our standard needle-free infusion extension sets are rated for continuous backpressure up to 45 psi (3.1 bar), suitable for standard gravity drop and volumetric IV infusion pumps. For radiology and high-pressure power injection applications (such as CT contrast media injection), we manufacture high-pressure microbore extension lines rated up to 325 psi (22.4 bar) with flow rates exceeding 250 mL/min.
Angiplast provides a comprehensive regulatory dossier package to support importer registration with national health authorities (such as US FDA, EU Competent Authorities, ANVISA, MOH). The dossier includes: ISO 13485 QMS Certificate, CE Declaration of Conformity, Free Sale Certificate (FSC), Biocompatibility Test Reports (ISO 10993 cytotoxicity, sensitization, systemic toxicity), ETO Sterilization Validation Reports (ISO 11135), ISO 80369-7 Gauging Compliance, and 5-Year Real-Time Stability Data.
For custom OEM/CDMO projects (including private label blister packaging, customized tube lengths, integrated clamps, and multi-gang manifold configurations), MOQs typically start at 10,000 to 25,000 units depending on line complexity. Devices are supplied individually sealed in medical-grade paper/film Tyvek pouches with UDI barcoding, inner box packaging, and heavy-duty corrugated export cartons.
Get in touch with our expert sales and engineering team for technical specifications, product samples, OEM customization, and competitive factory-direct quotations.
